NexgenRx Past Earnings Performance
Past criteria checks 0/6
NexgenRx's earnings have been declining at an average annual rate of -5.8%, while the Insurance industry saw earnings growing at 15.2% annually. Revenues have been growing at an average rate of 9.9% per year.
Key information
-5.8%
Earnings growth rate
-5.9%
EPS growth rate
| Insurance Industry Growth | 20.6% |
| Revenue growth rate | 9.9% |
| Return on equity | -0.3% |
| Net Margin | -0.2% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Optimistic Investors Push NexgenRx Inc. (CVE:NXG) Shares Up 45% But Growth Is Lacking
May 21
We Discuss Why NexgenRx Inc.'s (CVE:NXG) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
May 10NexgenRx Inc.'s (CVE:NXG) Price Is Out Of Tune With Revenues
Mar 14Here's Why We Think NexgenRx (CVE:NXG) Might Deserve Your Attention Today
Mar 07Is Now The Time To Put NexgenRx (CVE:NXG) On Your Watchlist?
Oct 18Does NexgenRx (CVE:NXG) Deserve A Spot On Your Watchlist?
Nov 30What NexgenRx Inc.'s (CVE:NXG) 32% Share Price Gain Is Not Telling You
Aug 24Here's Why NexgenRx Inc.'s (CVE:NXG) CEO May Have Their Pay Bumped Up
Jun 03NexgenRx Inc.'s (CVE:NXG) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 19
How Much Is NexgenRx's (CVE:NXG) CEO Getting Paid?
Dec 28Revenue & Expenses Breakdown
How NexgenRx makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 15 | 0 | 11 | 0 |
| 31 Mar 24 | 15 | 0 | 10 | 0 |
| 31 Dec 23 | 14 | 0 | 10 | 0 |
| 30 Sep 23 | 14 | 0 | 9 | 0 |
| 30 Jun 23 | 13 | 0 | 9 | 0 |
| 31 Mar 23 | 13 | 0 | 9 | 0 |
| 31 Dec 22 | 13 | 0 | 8 | 0 |
| 30 Sep 22 | 13 | 3 | 8 | 0 |
| 30 Jun 22 | 13 | 4 | 7 | 0 |
| 31 Mar 22 | 12 | 4 | 7 | 0 |
| 31 Dec 21 | 12 | 4 | 6 | 0 |
| 30 Sep 21 | 11 | 2 | 6 | 0 |
| 30 Jun 21 | 11 | 2 | 6 | 0 |
| 31 Mar 21 | 11 | 2 | 6 | 0 |
| 31 Dec 20 | 11 | 2 | 7 | 0 |
| 30 Sep 20 | 10 | 1 | 7 | 0 |
| 30 Jun 20 | 10 | 0 | 7 | 0 |
| 31 Mar 20 | 10 | 0 | 8 | 0 |
| 31 Dec 19 | 10 | 0 | 7 | 0 |
| 30 Sep 19 | 9 | 0 | 7 | 0 |
| 30 Jun 19 | 9 | 0 | 7 | 0 |
| 31 Mar 19 | 8 | 0 | 7 | 0 |
| 31 Dec 18 | 7 | -1 | 6 | 0 |
| 30 Sep 18 | 6 | -1 | 6 | 0 |
| 30 Jun 18 | 6 | -1 | 5 | 0 |
| 31 Mar 18 | 6 | -1 | 5 | 0 |
| 31 Dec 17 | 6 | -1 | 5 | 0 |
| 30 Sep 17 | 6 | 0 | 4 | 0 |
| 30 Jun 17 | 6 | 0 | 4 | 0 |
| 31 Mar 17 | 6 | 1 | 4 | 0 |
| 31 Dec 16 | 6 | 1 | 4 | 0 |
| 30 Sep 16 | 5 | 0 | 4 | 0 |
| 30 Jun 16 | 5 | 0 | 4 | 0 |
| 31 Mar 16 | 5 | 0 | 4 | 0 |
| 31 Dec 15 | 5 | 0 | 4 | 0 |
| 30 Sep 15 | 5 | 0 | 4 | 0 |
| 30 Jun 15 | 4 | 0 | 4 | 0 |
| 31 Mar 15 | 4 | 0 | 4 | 0 |
| 31 Dec 14 | 4 | 0 | 4 | 0 |
| 30 Sep 14 | 4 | 0 | 4 | 0 |
| 30 Jun 14 | 4 | 0 | 3 | 0 |
| 31 Mar 14 | 5 | 0 | 3 | 0 |
| 31 Dec 13 | 5 | 1 | 3 | 0 |
Quality Earnings: NXG is currently unprofitable.
Growing Profit Margin: NXG is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NXG is unprofitable, and losses have increased over the past 5 years at a rate of 5.8% per year.
Accelerating Growth: Unable to compare NXG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NXG is unprofitable, making it difficult to compare its past year earnings growth to the Insurance industry (38.2%).
Return on Equity
High ROE: NXG has a negative Return on Equity (-0.32%), as it is currently unprofitable.